Centrally administered insulin potentiates the pressor response to angiotensin II

Regulatory Peptides

Volumn 163, Issue 1-3, 2010, Pages 57-61

  Mayer, Marcos A ^a   Giani, Jorge F ^a   Höcht, Christian ^a   Silberman, Ezequiel A ^a   Muñoz, Marina C ^a   Taira, Carlos A ^a   Dominici, Fernando P ^a   Puyó, Ana M ^a   Fernández, Belisario E ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Angiotensin; Blood pressure; Insulin; Intracerebroventricular; MAPK

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANGIOTENSIN II; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; RINGER SOLUTION;

ANIMAL EXPERIMENT; ARTICLE; BRAIN; CONTROLLED STUDY; DOSE RESPONSE; ENZYME PHOSPHORYLATION; HYPOTHALAMUS; INFUSION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT;

ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; FLAVONOIDS; INSULIN; MALE; MITOGEN-ACTIVATED PROTEIN KINASES; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA; RATTUS;

EID: 77953911803     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2010.04.001     Document Type: Article

References (33)

1. Brands M.W., Hildebrandt D.A., Mizelle H.L., Hall J.E. Sustained hyperinsulinemia increases arterial pressure in conscious rats. Am J Physiol 1991, 260:764-768.
2. Brands M.W., Harrison D.L., Keen H.L., Gardner A., Shek E.W., Hall J.E. Insulin-induced hypertension in rats depends on an intact renin-angiotensin system. Hypertension 1997, 29:1014-1019.
3. Fang T.C., Huang W.C. Angiotensin receptor blockade blunts hyperinsulinemia-induced hypertension in rats. Hypertension 1998, 32:235-242.
4. Meehan W.P., Buchanan T.A., Hsueh W. Chronic insulin administration elevates blood pressure in rats. Hypertension 1994, 23:1012-1017.
5. Nakata T., Takeda K., Hatta T., Kiyama M., Moriguchi J., Miki S., Kawa T., Morimoto S., Nakamura K., Uchida A., Itoh H., Sasaki S., Nakagawa M. Blockade of angiotensin II receptors inhibits the increase in blood pressure induced by insulin. J Cardiovasc Pharmacol 1998, 31:248-252.
6. Menegon L.F., Zaparolli A., Boer P.A., de Almeida A.R., Gontijo J.A.R. Long-term effects of intracerebroventricular insulin microinjection on renal sodium handling and arterial blood pressure in rats. Brain Res Bull 2008, 76:344-348.
7. Schultz-Klarr S., Wright-Richey J., Dunbar J.C. Plasma glucose, insulin and cardiovascular responses after intravenous intracerebroventricular injections of insulin, 2-deoxyglucose and glucose in rats. Diabetes Res Clin Pract 1994, 26:81-89.
8. Liu J., da Silva A.A., Tallam L.S., Hall J.E. Chronic central nervous system hyperinsulinemia and regulation of arterial pressure and food intake. J Hypertens 2006, 24:1391-1395.
9. Muntzel M., Morales J., Akensefunmi A. Converting enzyme inhibition with captopril abolishes sympathoexcitation to euglycemic hyperinsulinemia in rats. Am J Hypertens 2001, 14:592-598.
10. Rahmouni K., Morgan D.A., Morgan G.M., Liu X., Sigmund C.D., Mark A.L., Haynes W.G. Hypothalamic PI3K and MAPK differentially mediate regional sympathetic activation to insulin. J Clin Invest 2004, 114:652-658.
11. Veerasingham S.J., Raizada M.K. Brain renin-angiotensin system dysfunction in hypertension: recent advances and perspectives. Br J Pharmacol 2003, 139:191-202.
12. Wei S.G., Yu Y., Zhang Z.H., Weiss R.M., Felder R.B. Angiotensin II-triggered p44/42 mitogen-activated protein kinase mediates sympathetic excitation in heart failure rats. Hypertension 2008, 52:342-350.
13. Yang H., Raizada M.K. MAP kinase-independent signaling in angiotensin II regulation of neuromodulation in SHR neurons. Hypertension 1998, 32:473-481.
14. Yang H., Raizada M.K. Role of phosphatidylinositol 3-kinase in angiotensin II regulation of norepinephrine neuromodulation in brain neurons of the spontaneously hypertensive rat. J Neurosci 1999, 19:2413-2423.
15. Wei Y., Sowers J.R., Nistala R., Gong H., Uptergrove G.M., Clark S.E., Morris E.M., Szary N., Manrique C., Stump C.S. Angiotensin II-induced NADPH oxidase activation impairs insulin signaling in skeletal muscle cells. J Biol Chem 2006, 281:35137-35146.
16. NRC (National Research Council) Guide for the Care and Use of Laboratory Animals 1996, National Academy Press, Washington DC. 7th ed.
17. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 1986, Academic Press, New York. 2nd. ed.
18. Ufnal M., Dudek M., Żera M., Szczepańska-Sadowska E. Centrally administered interleukin-1 beta sensitizes to the central pressor action of angiotensin II. Brain Res 2006, 1100:64-72.
19. Palkovitz M., Brownstein M. Microdissection of brain areas by the punch technique. Int Brain Res Org 1983, 1-36. A.C. Cuello (Ed.).
20. Giani J.F., Gironacci M.M., Muñoz M.C., Peña C., Turyn D., Dominici F.P. Angiotensin-(1 7) stimulates the phosphorylation of JAK2, IRS-1 and Akt in rat heart in vivo: role of the AT1 and Mas receptors. Am J Physiol Heart Circ Physiol 2007, 293:1154-1163.
21. 2+ signaling and phosphatidylinositol 4, 5-bisphosphate hydrolysis induced by Gq protein-coupled receptor agonists through an mTOR-dependent pathway. Endocrinology 2007, 148:3246-3257.
22. Giacchetti G., Sechi L., Griffin C., Don B., Mantero F., Schambelan M. The tissue renin-angiotensin system in rats with fructose-induced hypertension: overexpression of type 1 angiotensin II receptor in adipose tissue. J Hypertens 2000, 18:695-702.
23. Mayer M.A., Höcht C., Gironacci M., Opezzo J.A.W., Taira C.A., Fernández B.E., Puyó A.M. Hypothalamic angiotensinergic-noradrenergic systems interaction in fructose induced hypertension. Regul Pept 2008, 146:38-45.
24. Kamide K., Rakugi H., Higaki J., Okamura A., Nagai M., Moriguchi K., Ohishi M., Satoh N., Tuck M., Ogihara T. The renin-angiotensin and adrenergic nervous system in cardiac hypertrophy in fructose-fed rats. Am J Hypertens 2002, 15:66-71.
25. Shinozaki K., Ayajiki K., Nishio Y., Sugaya T., Kashiwagi A., Okamura T. Evidence for a causal role of the renin-angiotensin system in vascular dysfunction associated with insulin resistance. Hypertension 2004, 43:255-262.
26. Lu H., Duanmu Z., Scislo T., Dunbar J.C. The co-existence of insulin mediated decreased mean arterial pressure and increased sympathetic nerve activity is not mediated by the baroreceptor reflex and differentially by hypoglycemia. Clin Exp Hypertens 1998, 20:165-183.
27. Morgan D.A., Balon T.W., Ginsberg B.H., Mark A.L. Nonuniform regional sympathetic nerve responses to hyperinsulinemia in rats. Am J Physiol 1993, 264:423-427.
28. Muntzel M., Beltz T., Mark A.L., Johnson A.K. Anteroventral third ventricle lesions abolish lumbar sympathetic responses to insulin. Hypertension 1994, 23:1059-1062.
29. Muntzel M., Morgan D.A., Mark A.L., Johnson A.K. Intracerebroventricular insulin produces nonuniform regional increases in sympathetic nerve activity. Am J Physiol 1994, 267:R1350-R1355.
30. Seyedabadi M., Goodchild A.K., Pilowsky P.M. Differential role of kinases in brain stem of hypertensive and normotensive rats. Hypertension 2001, 38:1087-1092.
31. Miura S., Zhang J., Matsuo Y., Saku K., Karnik S.S. Activation of extracellular signal-activated kinase by angiotensin II-induced Gq-independent epidermal growth factor receptor transactivation. Hypertens Res 2004, 27:765-770.
32. Zucker I.H., Gao L. The regulation of sympathetic nerve activity by angiotensin II involves reactive oxygen species and MAPK. Circ Res 2005, 97:737-739.
33. Dziennis S., Habecker B.A. Cytokine suppression of dopamine-betahydroxylase by extracellular signal-regulated kinase-dependent and -independent pathways. J Biol Chem 2003, 278:15897-15904.